Your fasting glucose is high, yet nobody explains why. Here's the biological reason.

TCF7L2 is a transcription factor that controls the genes responsible for insulin secretion and glucose metabolism in your pancreatic beta cells. When glucose rises, TCF7L2 helps orchestrate the cascade of insulin release. It’s one of the most important switches in blood sugar regulation.

The T allele at rs7903146 is carried by roughly 30 percent of people and is the strongest common genetic risk factor for type 2 diabetes. If you carry this variant, your beta cells don’t respond as sharply to rising glucose. Incretin hormones, which normally amplify insulin secretion after you eat, fail to trigger an adequate response. Your pancreas releases insulin, but it’s blunted and delayed.

You feel this as persistent elevated fasting glucose despite normal eating patterns. Your morning glucose stays elevated because your overnight insulin secretion is insufficient to clear the glucose your liver produces. Over time, the variant increases diabetes risk substantially.

MTNR1B codes for the melatonin receptor on pancreatic beta cells. Melatonin is a hormone that tells your body it’s nighttime. When melatonin binds to this receptor, it suppresses insulin secretion. This is normal; your body should produce less insulin at night. But in some people, melatonin signaling is exaggerated.

The G allele at rs10830963, present in roughly 30 percent of the population, causes the melatonin receptor to be oversensitive. Your beta cells respond too strongly to the melatonin signal, shutting down insulin production too aggressively. Over a night of fasting, without sufficient insulin to clear it, your liver keeps releasing glucose and your blood sugar climbs.

You wake with high fasting glucose even though you’ve been fasting properly. Your insulin levels at dawn are suppressed. This pattern is especially common if your fasting glucose is elevated but your glucose tolerance after eating is relatively normal. The problem is specifically nocturnal insulin suppression.

KCNJ11 codes for an ATP-sensitive potassium channel on pancreatic beta cells. This channel is part of the glucose-sensing mechanism. When glucose rises, ATP levels rise inside the beta cell. ATP closes the potassium channel. That electrical change triggers calcium influx and insulin secretion. The channel is the first domino in the insulin release cascade.

The K allele at rs5219, carried by roughly 35 to 40 percent of people, weakens the ability of ATP to close the potassium channel. The electrical signal gets muddied. Glucose rises, but the potassium channel doesn’t respond as sharply. Your beta cells don’t recognize the glucose signal as urgently as they should. Insulin secretion is delayed and reduced.

Your fasting blood sugar reflects this sluggish response. Your pancreas eventually releases insulin, but it takes higher glucose levels to trigger it. You may notice that your blood sugar is fine after a meal with protein and fat, but elevated first thing in the morning when there’s been no stimulus to wake up the response.

SLC30A8 codes for a zinc transporter that loads zinc into secretory vesicles inside pancreatic beta cells. Zinc is essential for insulin crystallization. Insulin is synthesized as a precursor and must be repackaged into tight crystals with zinc and other molecules. Only crystallized insulin can be stored and released efficiently. Without adequate zinc transport, insulin accumulates in loose, dysfunctional form inside the cell.

The W allele at rs13266634, present in roughly 30 percent of people, reduces the efficiency of zinc transport into the vesicles. Your beta cells make insulin normally, but they can’t package it properly. It either leaks out uselessly or sits trapped inside the cell. The net effect is insulin deficiency in the bloodstream despite normal beta cell function.

Your fasting glucose is elevated because insulin isn’t available to suppress hepatic glucose production overnight. Your pancreas is working hard, but the insulin it produces doesn’t reach your bloodstream effectively. You may have normal or even elevated fasting insulin levels despite impaired glucose control, because dysfunctional insulin is still being measured.

FTO, the fat mass and obesity gene, controls appetite signaling and metabolic rate. The gene affects how your brain interprets fullness signals and how readily your body stores energy as fat. Variants in FTO also impair insulin signaling directly in muscle and fat tissue, independent of weight gain.

The A allele at rs9939609, carried by roughly 45 percent of people with European ancestry, drives obesity and metabolic dysfunction. People with this variant tend to gain weight more easily, become insulin resistant, and experience exaggerated glucose dysregulation. The allele impairs satiety signaling, so you eat more. It also shifts your metabolism toward fat storage and away from glucose utilization.

Your fasting glucose is elevated partly because of excess weight and resulting insulin resistance, and partly because the variant directly impairs glucose sensing in muscle. Even if you lose weight, the variant creates a biological push toward insulin resistance. You’re fighting a headwind that thinner people without the variant don’t face.

PPARG codes for a nuclear receptor that regulates fat cell differentiation and insulin sensitivity. When functioning normally, PPARG guides your body to store excess energy in subcutaneous (under-skin) fat, which is metabolically healthy. PPARG also activates genes that improve insulin sensitivity in muscle and liver.

The Pro12 allele, present in roughly 75 percent of people, shifts your metabolism toward efficient fat storage but away from insulin sensitivity. You gain weight more readily, especially in visceral (belly) fat, which is metabolically toxic. This visceral fat produces inflammatory molecules that impair insulin signaling throughout your body. Your muscles and liver become resistant to insulin.

Your fasting glucose is elevated because your muscle cells are ignoring insulin’s signal to take up glucose. Your liver continues producing glucose overnight, and your body can’t suppress that production effectively. You also find that standard dietary interventions don’t work well. The variant creates intrinsic resistance to the metabolic improvements that diet usually provides.